Condition category
Signs and Symptoms
Date applied
30/09/2004
Date assigned
30/09/2004
Last edited
22/04/2015
Prospective/Retrospective
Retrospectively registered
Overall trial status
Stopped
Recruitment status
Stopped

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr A P Baranowski

ORCID ID

Contact details

Pain Management Department
National Hospital for Neurology & Neurosurgery
Queen Square
London
WC1N 3BG
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N0263139706

Study information

Scientific title

Does magnesium augment the pain relieving effects of low dose intravenous lidocaine (lignocaine) in patients with chronic non malignant pain? A randomised double-blind crossover study

Acronym

Study hypothesis

Can the addition of magnesium sulphate to systemic low dose lidocaine treatment for chronic pain improve the intensity and duration of pain reduction?

Ethics approval

Not provided at time of registration

Study design

Randomised double-blind crossover study

Primary study design

Interventional

Secondary study design

Randomised cross over trial

Trial setting

Not specified

Trial type

Treatment

Patient information sheet

Condition

Signs and Symptoms: Pain

Intervention

1. Lignocaine
2. Non lignocaine

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Change in pain score following treatment.

Secondary outcome measures

Number of patients receiving >50% pain relief, pain relief intensity and sleep interference, duration of pain relief, number and frequency of adverse events, effect on blood pressure.

Overall trial start date

01/04/2004

Overall trial end date

31/03/2005

Reason abandoned

Eligibility

Participant inclusion criteria

20 patients from Pain Management

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

20

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

01/04/2004

Recruitment end date

31/03/2005

Locations

Countries of recruitment

United Kingdom

Trial participating centre

National Hospital for Neurology & Neurosurgery
London
WC1N 3BG
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Funder name

University College London Hospitals NHS Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes